Pharmacist Follow-up, a Qualitative Study of Patient Experience
Recruitment status was Active, not recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
A pharmacist follow-up procedure is under development. Patients with coronary heart disease (CHD) is being followed up by a pharmacist for one year with three meetings; at discharge from hospital, after three months and after one year. The evaluation is basically based on quantitative measures as achievement of therapeutic goals, number of drug related problems detected, hospitalisations etc. However, the patients' own experience with the follow-up procedure cannot be evaluated using these measures. Thus, a qualitative approach is needed. In this study, a total of four patients participating in the follow-up will be included and interviewed. A semistructured interview guide will be used. Interviews will be taped, transcribed and analyzed with the intention to explore how patients experience the follow-up from the pharmacist. A thoruough content analysis will be performed. Patients included must have met the pharmacist at least twice. The pharmacist in charge of the follow-up will recruit patients and hand out study information. Patients will reply to the principal investigator of the study and thus kept anonymous for the pharmacist in charge of the follow-up. No pressure will be put on the patients to join, but it will be emphasized that it will help evaluating the procedure.
| Condition |
|---|
|
Patient Satisfaction Patient Preference |
| Study Type: | Observational |
| Official Title: | Pharmacist Follow-up of Patients With Coronary Heart Disease. A Qualitative Study of Patient Experience. |
- Qualitative evaluation of the impact of pharmacist follow-up via interviews with the participating patients [ Time Frame: 3 months or 1 year ] [ Designated as safety issue: No ]In the pharmacist follow-up procedure under development, patients have individual "consultations" with a pharmacist three times. Patients are recruited to this study at the second or third consultation. Interviews will be performed with patients included to explore how patients' experience this follow-up procedure. Outcome measures from patient interviews can be counted. In qualitative research, the content of the interviews are thoroughly analysed with focus on the meaning of the informant's/interviewee's sayings. Outcomes will be presented as overall themes touched by the informants.
| Enrollment: | 4 |
| Study Start Date: | March 2010 |
| Estimated Study Completion Date: | July 2010 |
| Estimated Primary Completion Date: | July 2010 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
Study group
Patients who are included in the pharmacist follow-up procedure
|
Eligibility| Ages Eligible for Study: | 18 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Patients included in the study "Pharmacist follow-up of patients with CHD".
Inclusion Criteria:
- must have met the pharmacist at least twice
- living within the area of Tromsoe city so that interviews are possible
Exclusion Criteria
- none as patients are already enrolled in another study
Contacts and Locations| Norway | |
| University of Tromsoe | |
| Tromso, Norway, 9037 | |
| Principal Investigator: | Lars Smaabrekke, PhD | University of Tromso |
| Study Chair: | Beate H Garcia, PhDstudent | Hospital Pharmacy of North Norway Trust |
More Information
No publications provided
| Responsible Party: | Lars Smaabrekke, University of Tromsø |
| ClinicalTrials.gov Identifier: | NCT01131715 History of Changes |
| Other Study ID Numbers: | SHAN-002 |
| Study First Received: | April 30, 2010 |
| Last Updated: | May 26, 2010 |
| Health Authority: | Norway: Ethics Committee |
Keywords provided by Hospital Pharmacy of North Norway Trust:
|
Qualitetive interview Coronary heart disease (CHD) Patient experience Patient perception |
Additional relevant MeSH terms:
|
Coronary Artery Disease Myocardial Ischemia Coronary Disease Heart Diseases |
Cardiovascular Diseases Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases |
ClinicalTrials.gov processed this record on June 18, 2013